AbbVie Ups Its IBD Game With Latest Crohn’s Data For Rinvoq

Last Of Three Phase III Readouts Also Positive

 
• By Mandy Jackson
Chain of arrows blocks
Crohn's disease is an important building block in AbbVie's Rinvoq strategy • Source: Shutterstock

More from Clinical Trials

More from R&D